Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansType XVIII collagen degradation products in acute lung injuryCooperation between integrin alphavbeta3 and VEGFR2 in angiogenesisGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionAntiangiogenic gene therapy of cancer: recent developmentsMatricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsHeparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell MigrationDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsαV integrins in angiogenesis and cancerMaterials as stem cell regulatorsMammalian collagen IVHuman alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activityA heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesisVicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activitiesThe CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.An antiangiogenic neurokinin-B/thromboxane A2 regulatory axisLack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis.Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesivenessOverexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.Integrins as Therapeutic Targets for Respiratory DiseasesInhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cellsCD40L and Its Receptors in Atherothrombosis-An UpdateFunction of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressorsPharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.Angiogenesis and chronic kidney disease.Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities.Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.E-selectin is required for the antiangiogenic activity of endostatinVEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomyArresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.The effect of the single substitution of arginine within the RGD tripeptide motif of a modified neurotoxin dendroaspin on its activity of platelet aggregation and cell adhesion.T-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via alphavbeta3 and alpha5beta1 integrins.Anti-angiogenic peptides for cancer therapeuticsVascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosisRecombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors
P2860
Q21710680-A2D3175C-82D9-4F07-8C46-63E575762FD5Q22000109-8E0B0724-4E0F-4BE9-8F52-C2897C5564B4Q24318607-CE8699BE-663D-4071-96AB-C01FE22E5EF0Q24568374-CE61ACD9-56BA-4EEA-B3F4-E5E250570137Q24803786-61F11AB1-F9F3-4029-BCEC-56E6ED5A455BQ26766481-E6ED6CC7-1770-4357-AEA7-75BA6185C0E7Q26777586-C7AE9E86-EF4D-4AA9-B666-739B8F98FB2CQ26801397-7632EA1D-9766-4961-A1C7-36A88988C1F9Q26851768-91ABE55C-C16A-4499-9D44-044C6CFE4C7EQ27021068-4299B9CD-21D0-4D46-BDB6-4A98F4296087Q28265884-1D39A7D9-8DE2-47FD-88FD-3D4383A14A9BQ28271413-E8BB0CE3-EAEF-48A8-94DB-0EFBDC396263Q28730956-188F61E0-D738-43A6-82B5-AD689E6DE01EQ28731921-0228790A-CCBF-4DE8-94EB-FA4ACD12125FQ28751757-FEB37A26-6EFB-47A8-86A8-BFD623124A9AQ30441368-7F38443C-35EA-4284-9A72-75C6030FFC79Q30480495-8151CD23-B8F5-4087-9F1A-190E2B0EF2C3Q30497785-0D3805A1-C87C-40E1-8E46-CB0D624D7C0FQ30524624-9FEB8344-7D74-415D-A375-E2F5CA14E662Q33414123-C1380B80-63D8-4DFA-B5E3-22534D58B9E8Q33668635-A83BB309-004A-44CD-97CA-4558E9EAB775Q33685500-70836BD4-72D2-4A9C-BF78-B6719137DD47Q33814059-79FCA708-9816-4F14-97E2-0F11E68EF2EFQ33864448-5482BE9A-92CC-4A6E-87FE-636D9DBA3C19Q33894448-D7771537-782A-4AA2-B28D-D4EF6634DBB7Q34075013-281F5464-5F1C-4152-8AAF-AAC39089DB92Q34102845-66E7A798-1E71-432C-8A0E-12A0218FEAEAQ34230899-E5986474-9964-4CE0-9D00-3746A9B9C5DCQ34262295-B4405AA8-3ECD-4435-85FF-760356F3CC19Q34331022-FA55B208-0011-4319-ABCA-5BB2566FA51DQ34333828-B357C607-F8ED-4BFA-8371-48689C971DEAQ34507203-64227B51-C610-4831-BADC-1FDEEBC98A36Q34541685-D9B3E7DC-A966-41E3-B75E-BE5ADCE64C63Q34774929-8B38007F-EFC2-428A-8A5E-B6DFECE5AE80Q35043016-D3B93A6D-C76E-4038-B587-4EFEACF57AB5Q35049227-D25497A6-BAE7-4945-91C6-3348FAEF9C9CQ35049228-B204E91B-892D-4DAE-8796-61BDE50FBD89Q35063753-77AA304F-D34F-49CD-99B0-5434F6879EBBQ35083731-FEC12EDA-AE8A-48AB-8741-4568FACA7D87Q35084870-8E2727FD-1C10-4168-9F8A-E9FE716B06EB
P2860
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@ast
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en-gb
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@nl
type
label
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@ast
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en-gb
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@nl
prefLabel
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@ast
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en-gb
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@nl
P2093
P2860
P921
P3181
P356
P1476
Human tumstatin and human endo ...... 3 and alpha 5 beta 1 integrins
@en
P2093
Akulapalli Sudhakar
Changqing Yang
Hikaru Sugimoto
Julie Lively
Michael Zeisberg
P2860
P304
P3181
P356
10.1073/PNAS.0730882100
P407
P577
2003-04-07T00:00:00Z